Adrenaline Versus Isoprenaline for Arrhythmia Induction

  • Andrei CismaruEmail author


AVNRT can be induced in the EP lab by atrial or ventricular stimulation in the basal state or after drug administration. The drug of choice is isoprenaline, but in some European countries, the lack of the drug demands efforts to search for other options. There is no study that compares efficacy of isoprenaline versus adrenaline for AVNRT induction in the EP lab. In our study we compared the two drugs in terms of efficacy and side effects.


  1. 1.
    Choi EK, Kumar S, Nagashima K, Lin KY, Barbhaiya CR, Chinitz JS, et al. Better outcome of ablation for sustained outflow-tract ventricular tachycardia when tachycardia is inducible. Europace. 2015;17:1571–9.CrossRefGoogle Scholar
  2. 2.
    Hariman RJ, Gomes JA, El-Sherif N. Catecholamine-dependent atrioventricular nodal reentrant tachycardia. Circulation. 1983;67:681–6.CrossRefGoogle Scholar
  3. 3.
    Toda I, Kawahara T, Murakawa Y, Nozaki A, Kawakubo K, Inoue H, et al. Electrophysiologial study of young patients with exercise related paroxysmal of palpitation: role of atropine and isoprenaline for initiation of supraventricular tachycardia. Br Heart J. 1989;61:268–73.CrossRefGoogle Scholar
  4. 4.
    Huycke EC, Lai WT, Nguyen NX, Keung EC, Sung RJ. Role of intravenous isoproterenol in the electrophysiological induction of atrioventricular node reentrant tachycardia in patients with dual atrioventricular node pathways. Am J Cardiol. 1989;64:1131–7.CrossRefGoogle Scholar
  5. 5.
    Brembilla-Perrot B, Terrier de la Chaise A, Pichene M, Aliot E, Cherrier F, Pernot C. Isoprenaline as an aid to the induction of catecholamine dependent supraventricular tachycardia during programmed stimulation. Br Heart J. 1989;61:348–55.CrossRefGoogle Scholar
  6. 6.
    Stellbrink C, Diem B, Schauerte P, Brehmer K, Schuett H, Hanrath P. Differential effects of atropine and isoproterenol on inducibility of atrioventricular nodal reentrant tachycardia. J Interv Card Electrophysiol. 2001;5:463–9.CrossRefGoogle Scholar
  7. 7.
    Katz DF, Hegeman TW, Aleong R. Use of isoproterenol for assessment of anterograde accessory pathway conduction properties in sedated asymptomatic patients with ventricular pre-excitation. J Innov Card Rhythm Manage. 2013;4:1428–33.Google Scholar
  8. 8.
    Oral H, Crawford T, Frederick M, Gadeela N, Wimmer A, Dey S, et al. Inducibility of paroxysmal atrial fibrillation by isoproterenol and its relation to the mode of onset of atrial fibrillation. J Cardiovasc Electrophysiol. 2008;19:466–70.CrossRefGoogle Scholar
  9. 9.
    Cismaru G, Rosu R, Muresan L, Puiu M, Andronache M, Hengan E, et al. The value of adrenaline in the induction of supraventricular tachycardia in the EP lab. Europace. 2014;16:1634–8.CrossRefGoogle Scholar
  10. 10.
    Calkins H, Sousa J, El-Atassi R, Schamltz S, Kadish A, Morady F. Reversal of antiarrhythmic drug effects by epinephrine: quinidine versus amiodarone. Am J Cardiol. 1992;19:347–52.CrossRefGoogle Scholar
  11. 11.
    Jazayeri M, VanWyhe G, Avitall B, McKinnie J, Tchou P, Akhtar M. Isoproterenol reversal of antiarrhythmic effects in patients with inducible sustained ventricular tachyarrhythmias. J Am Coll Cardiol. 1989;14:705–11.CrossRefGoogle Scholar
  12. 12.
    Markel ML, Miles WM, Prytowsky EN. The differential effects of isoproterenol on sustained ventricular tachycardia before and during antiarrhythmic therapy. J Am Coll Cardiol. 1987;9:227–8.Google Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Institut Gustave RoussyVillejuifFrance

Personalised recommendations